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Abstract
Background: Thyroid hormones are well known modulators of signal transduction. The effect of
hyper- and hypo-thyroidism on diacylglycerol/protein kinase C (DAG/PKC) signaling in
cardiomiocytes has been determined. Triiodothyronine (T3) has been shown to prevent the α1-
adrenoreceptor-mediated activation of PKC but does not alter the stimulation of enzyme and
hepatic metabolism by phorbol ethers. It has been suggested that the elevation of endogenous DAG
in senescent or hypothyroid cells changes the PKC-dependent response of cells to phorbol esters
and hormones. In the present study, was examined the formation of DAG and activation of PKC
in liver cells from rats of  different thyroid status.
Results: The results obtained provide the first demonstration of DAG accumulation in liver and
cell plasma membranes at age- and drug-dependent thyroid gland malfunction. The experiments
were performed in either the [14C]CH3COOH-labeled rat liver, liver slices or hepatocytes labeled
by [14C] oleic acid and [3H]arachidonic acid or [14C]palmitic acid as well as in the isolated liver cell
plasma membranes of 90- and 720-day-old rats of different thyroid status. The decrease of T4 and
T3 levels in blood serum of 720-day-old rats and mercazolil-treated animals was associated with
increases of both the DAG mass in liver and liver cell plasma membranes and newly synthesized
[14C]DAG level in liver and isolated hepatocytes. Hypothyroidism decreased PKC activity in both
membrane and cytosol as well as phospholipid and triacylglycerol synthesis in liver. These
hypothyroidism effects were restored in liver by injection of T4. T4 administration to the intact
animals of different ages decreased the DAG level in liver and isolated plasma membranes and the
content of newly synthesized DAG in liver. The reduction of DAG level in liver was not associated
with increasing free fatty acid level. DAG labeling ratio 14C/3H in liver slices of rats of different
thyroid state sharply differed from PL. DAG was relatively enriched in [14C]oleic acid whereas PL
were enriched in [3H]arachidonic acid.
Conclusions: The above data have indicated that thyroid hormones are important physiological
modulators of DAG level in rat liver and cell plasma membranes. Age- and drug-induced
malfunction of thyroid gland resulted in a prominent decrease of glycerolipid synthesis which may
promote DAG accumulation in liver.
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sn-1,2-Diacylglycerol plays a key role in lipid biosynthesis
and signal transduction in a variety of mammalian cells.
Thus, to maintain cellular homeostasis, intracellular DAG
levels must be tightly regulated. This is illustrated by evi-
dence that inappropriate accumulation of DAG contrib-
utes to cellular transformation. For example, cell lines that
overexpress PLCγ have a malignant phenotype [1]. Also,
cells transformed with one of several oncogenes have ele-
vated DAG levels [2]. Most of the evidences for this path-
ological effect centers on excessive and/or prolonged
activation of PKC, which is a common feature of the trans-
formed state, both in tumors and in cell cultures. Accumu-
lation of DAG with increased membrane-associated PKC
is the mechanism of spontaneous hepatocarcinogenesis
in choline-deficient rats [3,4]. Aortic endothelial cells
have been shown to contain particularly high basal levels
of polyunsaturated DAG together with a very high degree
of membrane-associated PKC, which is largely insensitive
to further activation [5]. Glucose-induced de novo synthe-
sis of DAG and sustained isozyme-selective PKC activa-
tion (especially PKC-β) contribute to the pathogenesis of
diabetic micro- and macroangiopathy [6]. The fed state
was associated with increased DAG level and PKC activity
in muscle tissue of insulin-resistant obese Zucker rats [7].
These changes in PKC are likely to exacerbate the hyperg-
lycaemia and hypertriglyceridaemia at obesity-induced di-
abetes. Hypothyroidism is frequently known to coexist
with diabetes [8]. Decreased thyroid hormone levels are
often observed in the experimentally diabetic animals [9].
However, little has been known about the effect of hy-
pothyroidism on DAG content in cells. It has been dem-
onstrated that activity of PLC and PLD was depressed [10],
and DAG level decreased [11] in thyroxine-induced cardi-
ac hypertrophy. In contrast, experimental hyperthy-
roidism caused a significant increase in inositol
trisphosphate formation and PLC activation in the per-
fused hearts while hypothyroidism was associated with a
decrease in this activity [12]. Hypothyroidism increased
the basal PLC-linked inositol phospholipid hydrolysis in
rat hypothalamus, whereas L-T4 supplementation to hy-
pothyroid rats resulted in a complete restoration of hy-
pothalamic inositol phosphate formation to the value of
euthyroid control [13].
Numerous investigations demonstrated a novel role of
thyroid hormones as modulators of signal transduction.
PKC is critical to the mechanism by which thyroid hor-
mones rapidly induce phosphorylation and nuclear trans-
location of mitogen-activated protein kinase and
subsequently potentiate both the antiviral and immu-
nomodulatory actions of IFNγ in cultured cells [14] and
regulate the exchange of signaling phospholipids (PL) in
hepatocytes [15,16]. It was found that L-T4 rapidly in-
duced the biphasic DAG accumulation and PKC activa-
tion in liver slices and isolated hepatocytes [17]. The effect
of L-T4 on PLC, -D, PKC, and DAG accumulation was too
rapid: from seconds to a few minutes. Perfusion of the liv-
er of hypothyroid rats with L-T4-containing solution dur-
ing 10 min increased the content of DAG in the liver [18].
However, the effect of hypothyroidism on basal level of
DAG in liver has not been determined.
In the present study, we have examined DAG level and
PKC activity in liver and isolated membranes during sus-
tained thyroid hormone stimulation and at different thy-
roid state of organism. Degradation of thyroid gland
function with aging or under the mercazolil action de-
creased PL and TAG synthesis in liver and increased the
DAG level in liver slices and isolated liver cell plasma
membranes. Hypothyroidism markedly decreased PKC
activity. L-T4 administration to intact or mercazolil-treat-
ed rats decreased DAG level and increased PL and TAG
synthesis in liver. These results provide the evidence that
thyroxine is crucial in lowering DAG by converting them
to PL and TAG during sustained hormone action.
Results and Discussion
The present work is aimed at the elucidation of the influ-
ence of thyroid functional status on the DAG level in liver
and plasma membranes. To determine the role of thyroid
hormones in the regulation of DAG level in liver, a com-
parison of euthyroid, mercazolil- and mercazolil+L-T4-
treated rats or intact animals after injection of L-T4 has
been made.
The results of investigation of thyroid hormones content
in blood serum of rats are given in Table 1. The thyroxine
and triiodothyronine levels are shown to be markedly
lower in blood serum of 720-day-old intact rats and mer-
cazolil-treated rats as compared to appropriate controls.
The data obtained are consistent with previous observa-
tions of age- and drug-induced thyroid gland malfunction
[19–21].
Aging promotes decline in signal transduction in activated
cells as evidenced by reductions in DAG and inosite phos-
phate generation [22,23]. There was also a pronounced
age-related increase of PLC activity, inositol 1,4,5-tri-
sphosphate and intracellular free calcium levels in human
resting granulocytes [24] and in rat brain cerebellum and
striatum [25,26]. We have determined the DAG (Fig.
1A,1B) and [14C]DAG (Fig. 2A, 3) accumulation in both
resting liver and cell plasma membranes of aged rats. Se-
nescent isolated [14C]oleic acid prelabeled hepatocytes
were found to contain higher basal levels of DAG: 7359 ±
746 as contrasted with 1171 ± 228 cpm/107 cells (P ≤
0.05, n = 5) in cells of adult animals. Mercazolil leads to a
further increase of DAG mass in liver (Fig. 1A) and isolat-
ed plasma membranes (Fig. 1B) of animals of differentPage 2 of 11
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DAG level in liver (Fig. 1A) and isolated membranes (Fig.
1B) and [14C]DAG in liver (Fig. 2B) of rats of different age.
However, T4 does not increase free 14C-fatty acid (FFA) ac-
cumulation in liver (Fig. 2C). Thus, the impact of DAG li-
pase in hormone-related decrease of DAG level in liver
can be ruled out. Age- and mercazolil-related increase of
newly synthesized [14C]DAG in liver slices was observed
(Fig. 3). The administration of L-T4 to mercazolil-treated
rats reduced [14C]DAG accumulation in liver slices. Mer-
cazolil and L-T4 diminished the age peculiarities of
[14C]DAG level in liver. The latter observation is an indi-
cation that the observed thyroid status changes of organ-
ism at old age may contribute to the age-related changes
of DAG level in liver.
Multiple sources of DAGs in mammalian cells have been
determined [for review see [27]]. The DAG is generally de-
rived from phosphatidic acid by the action of phosphatid-
ic acid phosphatase (PAP). This reaction is the
commitment reaction for the synthesis of TAG and the ni-
trogen-containing PLs – PC, PE and phosphatidylserine.
There are different potential pathways of DAG generation
which utilize PIP2 and PC in resting cells. Some reports of
PE and phosphatidylinositol (PI) hydrolysis by PLC/PLD
and DAG production were published [28,29]. To assess
the possibility of PL conversion to DAG in liver slices, we
labeled DAG and PL with two different fatty acids,
[14C]oleic acid and [3H]arachidonic acid (Table 2). DAG
was relatively enriched in [14C]oleic acid, whereas PL were
enriched in [3H]arachidonic acid. The results obtained
suggest that in liver of hypothyroid animals the accumu-
lated DAG are unlikely to be products of phospholipase-
catalised PL hydrolysis. However, radiolabelling will miss
some DAG since the fatty acid species chosen will not nec-
essarily label all groups of DAG that may be relevant.
Therefore, it is possible that some other molecular species
of PL could be the source of DAG in liver of animals of dif-
ferent thyroid state.
It has been demonstrated that DAG accumulates and PC
synthesis decreases in the livers of rats fed with choline-
deficient diet [3,4,30]. Diet treatment induced the PKC ac-
tivation in the hepatic plasma membrane. These changes
were reversible when choline was returned back to the diet
of the deficient animals. Thyroid hormone stimulates
lipogenesis by the induction of enzymes in the lipogenic
pathway. Acyl-CoA-glycero-3-phosphate acyl-
transpherase, which is known to catalyze a rate-limiting
step for the synthesis of phosphatidic acid in rat liver [31],
as well as liver diacylglycerol acyltransferase [32] are de-
pendent on thyroid gland function. The PL synthesis by
phosphotransferase reaction of DAG with CDPcholine or
CDPetanolamine which are generated by the actions of
specific cytidyltransferases is under thyroid hormone con-
trol, too [33–35]. Results of this study provide further ev-
idence that hepatic PC and TAG synthesis is dependent on
thyroid status of organism (Fig. 4). It was found that the
amount of newly synthesized PC and TAG decreased at
old age and in liver homogenates of mercazolil-treated
animals. The reduction of 14C-glycerolipid level was cor-
rected by L-T4-treatment of the hypothyroid rat. L-T4 ad-
ministration to the intact (Fig. 2A,2B) or hypothyroid
(Fig. 3) rats reduced the amount of de novo synthesized
DAG in liver and increased the synthesis of PLs de novo in
isolated hepatocytes [16]. All these experimental observa-
tions taken together indicate that drug- and age-depend-
Table 1: Blood serum thyroxine and triiodothyronine content in rats of different age and thyroid status
Animals Age
90-day-old 720-day-old
T4 T3 T4 T3
Control 88.0 ± 6.9 1.5 ± 0.07 58.2 ± 3.2* 0.82 ± 0.0*
Mercazolil-treated 48.6 ± 0.9** 0.3 ± 0.08** 20.6 ± 4.26** 0
Thyroxine-treated 410 ± 51.0*** 5.86 ± 0.48*** 270 ± 10.0*** 3.9 ± 0.09***
The T4 and T3 content in blood serum was determined by radioimmunoassay kits. The amount of thyroid hormones in serum was represented as 
nmol per liter. Treatment of the rats by mercazolil was performed as described in "Materials and Methods".T4 (200 µg/100 g body weight) was 
injected to the normal rats three times a week. The last hormone injection was made 48 h prior to killing. Results are mean ± S.E. of 8 individual 
experiments. Here and in Table 2 and Figures 1,2,3,4,5 one experiment is equivalent to measurement of the parameters studied in a sample of 
serum or liver of a single animal. *p < 0.05 vs. 90-day-old rats, **p < 0.05 and *** p < 0.001 vs. control.Page 3 of 11
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Changes in total DAG mass in liver and liver cell plasma membranes following treatment of rats with merca-
zolil or thyroxine. A, liver homogenates. B, isolated liver cell plasma membranes. T4 (200 µg/100 g weight) was injected to
the normal rats three times a week. The last hormone injection was made 48 h prior to killing. Control rats received the same
volume of 0.9% NaCl. Mercazolil was injected to the animals and lipids were extracted and separated as described in "Materials
and Methods". The intensity of lipid spots was estimated by densitometry using a LKB Ultroscan laser densitometer. Results
are mean ± S.E. of four individual experiments. * P < 0.05 vs. 90-day-old rats, ** P < 0.001 vs. control rats, *** P < 0.001 vs. mer-
cazolil-treated rats.Page 4 of 11
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Age- and thyroxine-dependent fluctuations of newly synthesized [14C]-DAG and [14C]-FFA level in liver. The
liver lipids were labeled by [14C]CH3COOH as described in "Materials and Methods". T4 (200 µg/100 g weight) was injected to
the normal rats 15, 30 and 60 min prior to killing. Control rats received the same volume of 0.9% NaCl. Lipids were extracted
and separated as described in "Materials and Methods" and the radioactivity was determined by liquid scintillation counter.
Results are mean ± S.E. of six individual experiments. * P < 0.001 vs. 90-day-old rats, ** P < 0.05, *** P < 0.001 vs. control rats.Page 5 of 11
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[14C]-DAG accumulation in liver slices of rats of different age and thyroid status. Mercazolil was injected to the
animals as described in "Materials and Methods". T4 (10 µg/100 g weight) was injected to the mercazolil-treated rats 48 h prior
to killing. Control rats received the same volume of 0.9% NaCl. The liver slices were labeled by incubation in Eagle medium
containing 10% fetal calf serum, 100 units/liter streptomycin, 100 units/liter penicillin, 13 mg/ml gentamycin and 2.5 µCi/ml of
[14C]oleic acid for 1 h in 95% O2/5% CO2 atmosphere at 37°C. The lipids were extracted and analyzed as described in "Mate-
rials and Methods". Results are mean ± S.E. of six individual experiments. * P < 0.05 vs. 90-day-old rats, ** P < 0.05 vs. control
rats, *** P < 0.05 vs. mercazolil-treated rats.Page 6 of 11
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hepatic lipogenesis.
In contrast with diabetes[6], dietary-induced insulin re-
sistance [7] and choline-deficiency [3,4], there were no
changes in DAG/PKC signalling in skeletal muscle and liv-
er due to normal aging [36]. Hepatic PKC was not activat-
ed despite high intracellular DAG in obese Zucker rats
[37]. The data on PKC activity at different thyroid status
are controversial, perhaps, due to various models of hy-
pothyroidism used [38,39]. In the present study, to deter-
mine if DAG accumulation in liver plasma membranes
and liver cells could be the reason of sustained PKC acti-
vation, the PKC activity in liver of euthyroid and hypothy-
roid mercazolil-treated rats has been investigated (Fig. 5).
There were only slight differences in subcellular distribu-
tion of PKC in liver cells of the two groups of rats. Howev-
er, the total PKC activity in the liver of mercazolil-treated
animals was less than in control rats. Addition of exoge-
nous DAG completely abolished the differences between
PKC activity in liver cells of eu- hypo- and hyperthyroid
rats [39]. It is known that prolonged incubation with
Figure 4
Newly synthesized [14C]-PC and [14C]-TAG in liver slices of rats of different age and thyroid status. Mercazolil
was injected to the animals as described in "Materials and Methods". T4 (10 µg/100 g weight) was injected to the mercazolil-
treated rats 48 h prior to killing. Control rats received the same volume of 0.9% NaCl. The liver slices were labeled by incuba-
tion in Eagle medium containing 10% fetal calf serum, 100 units/liter streptomycin, 100 units/liter penicillin, 13 mg/ml gentamy-
cin and 2.5 µCi/ml of [14C]palmitic acid for 1 h in 95% O2/5% CO2 atmosphere at 37°C. The lipids were extracted and
analyzed as described in "Materials and Methods". Results are mean ± S.E. of six individual experiments. * P < 0.05 vs. 90-day-
old rats, ** P < 0.05 vs. control rats, *** P < 0.05 vs. mercazolil-treated rats.Page 7 of 11
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see [40]]. In addition, evidence has been obtained for in-
creased degradation of PKC after prolonged cell incuba-
tion with phorbol ethers and DAG. Results of the present
study suggest that inappropriate DAG accumulation in
liver cells of hypothyroid animals contributes to PKC de-
pletion. However, the reduction of PKC isozyme expres-
sion can not be ruled out. Further work is required to
elucidate this point.
Overnight 12-O-tetradecanoylphorbol 13-acetate (TPA)
pretreatment appeared to down-regulate predominantly
the alfa-isoform of PKC in rat hepatocytes and to suppress
cell signalling in response to vasopressin, TPA and Ca2+
ionophore A23187 [41]. Previous data indicated that just
the phorbol 12-myristate 13-acetate but not its inactive
analog, phorbol 12-myristate 13-acetate 4-O-methyl
ether, activated linoleic acid incorporation into PL [15]
and phosphoinositide synthesis de novo in liver slices and
isolated hepatocytes [16]. PKC-dependent signalling has
been indicated in plasma membranes of young intact 90-
day-old rats. No effect has been found in plasma mem-
branes isolated from liver of 720-day-old mercazolil-treat-
ed rats. These findings suggest that the desensitization of
the response to agonist in cell of hypothyroid rats is de-
pendent on PKC down regulation at such pathological
state of organism.
Conclusions
In conclusion, results of the present study indicate thyroid
hormone as a potentially important physiological modu-
lator of DAG level in rat liver. Unlike our previous work
[17] were thyroxine (in physiological concentration) was
shown to induce PLC/PLD activation and short-lived
DAG accumulation in liver cells, we detected the promi-
nent DAG level decrease under unphysiological doses of
Figure 5
Effect of mercazolil on PKC activity in liver cells. Mercazolil was injected to the animals and PKC activity was deter-
mined as described in "Materials and Methods". Results are mean ± S.E. of four individual experiments. * P < 0.05 vs. control
rats.Page 8 of 11
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pendent decline of thyroid hormone level in blood serum
coincides with elevation of DAG content in liver and liver
cell plasma membranes. In contrast, under hypothyroid
status of organism synthesis of PL and TAG decreases in
liver. The reduction of glycerolipid synthesis and DAG lev-
el elevation can be corrected by thyroxine treatment of hy-
pothyroid rats. Thus, thyroid hormone-dependent
changes in DAG content are likely associated with glycer-
olipid synthesis. Extremely high basal DAG level in hy-
pothyroid liver coincides with a declined PKC activity in
both cytosol and membrane of liver cells. Stable altera-
tions in DAG metabolism in hypothyroid liver are sug-




[14C]oleic acid (58 mCi/mmol) and [3H]arachidonic acid
(60 Ci/mmol) – Amersham Corp., [14C]palmitic acid (58
mCi/mmol), [γ-32P]ATP (1000 Ci/mmol) and
[14C]CH3COOH (25 mCi/mmol) – BPO Isotop (Russia);
DEAE-52-cellulose from Whatman (England); silica gel
from Woelm (Germany). Phosphatidylserine was isolated
from ox brain; other lipid standards and histone H1 were
obtained from Sigma (USA). T4 and mercazolil (1-me-
thyl,2-mercaptoimidozol) were from Zdorov'e Trudyas-
chikhsya (Kharkov, Ukraine). T4 and T3
radioimmunoassay kits were from Minsk (Belarussia).
Other chemicals used were of chemically pure grade.
Animals
Adult 90- and 720-day-old male Wistar rats which had a
free access to food and water and were kept at 24°C on a
cycle of 12 h light/12 h darkness were used for experi-
ments. Mercazolil was injected intraperitoneally (1 mg/
100 g weight) in 0.9% NaCl to the experimental animals
every day during 16 days-experiment. In some cases, the
mercazolil-treated rats were injected intraperitoneally by
T4 (10 µg/100 g weight) 48 h prior to killing. Besides, T4
(200 µg/100 g weight) was injected to the normal rats 15,
30 and 60 min prior to killing or three times a week in
which case the last hormone injection was made 48 h pri-
or to killing. Control rats received 0.9% NaCl of the same
volume. The animals were starved overnight prior to ex-
periment.. The thyroid state of rats was monitored by ra-
dioimmunological determination of the T4 and T3 in
blood serum.
Experiments with liver slices
The 1 mCi of [14C]CH3COOH was intraperitoneally in-
jected to rats four times every 30 minutes for 2 hours [42].
The liver was perfused with 0.9% NaCl, then removed and
washed in Krebs-Henseleit buffer, pH 7.4, containing 2
mM CaCl2 and 0.2% BSA. Pre-labeled slices of liver were
used for [14C]-DAG and [14C]-FFA analysis. Besides, the
liver slices were labeled by incubation in Eagle medium
containing 10% fetal calf serum, 100 units/litre strepto-
mycin, 100 units/litre penicillin, 13 mg/ml gentamycin
and 2.5 µCi/ml of [14C]oleic acid and 2.5 µCi/ml [3H]ara-
chidonic acid or 2.5 µCi/ml [14C]palmitic acid alone for 1
h in 95% O2/5% CO2 atmosphere at 37°C. The lipids
were extracted and analyzed as described below.
Cell suspension experiments
Hepatocytes were isolated from the 90- and 720-day-old
male Wistar rats which had a free access to food and water
and were kept at 24°C on a cycle of 12 h light/12 h dark-
ness by the method described in [41]. Preparation of
hepatocytes was started between 9:00 and 10:00 a.m.
Cells (107/ml) were labeled by incubation in Eagle medi-
um containing 10% fetal calf serum, 100 units/liter strep-
tomycin, 100 units/liter penicillin, 13 mg/ml gentamycin
and 2.5 µCi/ml of [14C]oleic acid for 3 h in 95% O2/5%
CO2 atmosphere at 37°C. Before lipid extraction, cells
were washed twice with a Krebs-Henseleit buffer pH 7.4,
containing 2 mM CaCl2, 25 mM HEPES, 0.1% BSA. The li-
pids were extracted and analyzed as described below.
Isolation of liver cell plasma membranes
Plasma membranes were prepared using differential cen-
trifugation through various concentration of sucrose and
characterized by their specific marker enzymes as de-
scribed in [43]. The lipids were extracted and analyzed as
described below.
Extraction and separation of lipids
Lipids were extracted according to Folch et al. [44] and
phosphoinositides as described in [45]. The chloroform
Table 2: 14C/3H ratio of the 1,2-diacylglycerol and phospholipid 






DAG 2.33 ± 0.19 4.33 ± 0.56 3.17 ± 0.38
PC 1.24 ± 0.16 0.94 ± 0.16 0.93 ± 0.18
PE 0.69 ± 0.20 1.18 ± 0.15 0.44 ± 0.09
PI 1.32 ± 0.17 0.90 ± 0.09 0.44 ± 0.09
PIP 0.52 ± 0.15 0.39 ± 0.03 0.50 ± 0.12
PIP2 0.32 ± 0.04 0.44 ± 0.04 0.33 ± 0.07
Liver slices of 90-day-old rats were pre-labeled by [14C]oleic and 
[3H]arachidonic acids and lipids extracted and separated as described 
in "Materials and Methods". The data are mean ± S.E. of three individ-
ual experiments.Page 9 of 11
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ids were redissolved in chloroform/methanol (1:2, v/v)
and applied on TLC plates. For DAG and FFA isolation the
solvent system: hexane/diethyl ether/acetic acid (80:20:2,
v/v) was used; for PC and PE separation – chloroform/
methanol/acetic acid/water (25:15:4:2, v/v) and for PI,
PIP and PIP2 – chloroform/methanol/NH4OH (50:40:10,
v/v). Appropriate standards were applied on each plate for
quantification. The gel spots containing [14C/3H]lipids
were scraped and transferred to scintillation vials. Radio-
activity was measured by scintillation counter.
Protein kinase C enzyme assay
Activities of protein kinase C in the cytosol and in the
crude membrane fraction of liver cells were determined
after partial enzyme purification by chromatography on
DEAE-cellulose [46]. The activity of protein kinase C was
determined by the transfer of 32P from [γ-32P]ATP into H1
histone in the presence of phosphatidylserine and Ca2+
(0.2 mM). Since histone is a poor substrate for calcium-in-
sensitive isoforms of PKC, the predominant isoforms of
PKC detected were cPKC and aPKC. The enzyme activity
was expressed as pmoles of phosphate transferred from [γ-
32P]ATP into H1 histone per minute. The protein content
was determined by Bradford method [47].
Abbreviations
T4 – thyroxine, T3 – triiodothyronine, PKC – protein ki-
nase C, PI – phosphatidylinositolphosphate, PIP – phos-
phatidylinositol 4-phosphate, PIP2 –
phosphatidylinositol 4,5-bisphosphate, PLC – phosphol-
ipase C, DAG – diacylglycerol, FFA – free fatty acids, TAG
– triacylglycerol, PL – phospholipids, PAP – phosphatidic
acid phosphatase, PC – phosphatidylcholine, PE – phos-
phatidylethanolamine, TPA – 12-O-tetradecanoylphorbol
13-acetate.
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